GILBERTI, MICOL
 Distribuzione geografica
Continente #
NA - Nord America 377
EU - Europa 332
AS - Asia 207
AF - Africa 2
OC - Oceania 1
Totale 919
Nazione #
US - Stati Uniti d'America 374
CN - Cina 122
IT - Italia 108
SE - Svezia 77
IE - Irlanda 75
SG - Singapore 59
FI - Finlandia 24
DE - Germania 13
BE - Belgio 12
FR - Francia 10
TR - Turchia 10
GB - Regno Unito 9
HK - Hong Kong 6
IN - India 6
CA - Canada 3
CI - Costa d'Avorio 2
IR - Iran 2
PT - Portogallo 2
VN - Vietnam 2
AU - Australia 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 919
Città #
Chandler 78
Dublin 73
Ann Arbor 55
Singapore 48
Dearborn 37
Parma 25
Boardman 21
Shanghai 21
Beijing 20
Ashburn 17
Nanjing 15
Brussels 12
Princeton 12
Izmir 10
Jinan 8
Nanchang 8
New York 8
Gravina di Catania 7
Helsinki 7
Fontanellato 6
Bologna 5
Kunming 5
Zhengzhou 5
Avola 4
Brescia 4
Colchester 4
Ferrara 4
Hangzhou 4
Hefei 4
Messina 4
Newcastle Upon Tyne 4
Pistoia 4
Pune 4
Rome 4
Wilmington 4
Des Moines 3
Marseille 3
Milan 3
Ottawa 3
Piacenza 3
San Mateo 3
Santa Clara 3
Shenyang 3
Abidjan 2
Ahmedabad 2
Carpi 2
Dong Ket 2
Fort Worth 2
Guangzhou 2
Hong Kong 2
Jacksonville 2
Lanzhou 2
Los Angeles 2
Ningbo 2
Odivelas 2
Palermo 2
Pisa 2
Saint-Fons 2
Tianjin 2
Vicenza 2
Woodbridge 2
Andover 1
Berlin 1
Bremen 1
Cambridge 1
Changsha 1
Chongqing 1
Curtarolo 1
Dallas 1
Danyang 1
Elyria 1
Fremont 1
Gatchina 1
Grafing 1
Hebei 1
Houston 1
Jiaxing 1
Langhirano 1
Lidköping 1
Matera 1
Melbourne 1
Novara 1
Phoenix 1
Redmond 1
San Gregorio di Catania 1
Seattle 1
Shengzhou 1
Taiyuan 1
Vezzano sul Crostolo 1
Zanjan 1
Zibo 1
Totale 641
Nome #
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 92
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 88
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 84
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 83
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 82
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 76
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 76
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 75
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 71
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 71
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 64
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 56
Yeast-based screening to discover therapies for Complex III assembly defects. 25
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 20
Totale 963
Categoria #
all - tutte 3.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 0 10 33 10 8 12 10 1 2
2020/202159 3 1 7 3 0 4 2 2 20 5 6 6
2021/202277 5 2 1 3 7 9 2 7 3 5 6 27
2022/2023307 35 39 31 16 17 26 8 17 97 1 11 9
2023/2024132 16 9 7 8 8 26 11 14 3 2 10 18
2024/2025103 10 15 25 22 31 0 0 0 0 0 0 0
Totale 963